Non-invasive imaging plays a central role in the diagnosis of non-ischaemic cardiomyopathies,
the assessment of prognosis, and monitoring of therapy. Three (3) fundamental questions
must be addressed clinically: 1) Is the left ventricular (LV) ejection fraction (EF)
preserved or reduced? 2) Is the structure of the LV normal or abnormal? 3) Are there
other myocardial tissue abnormalities that could account for the clinical presentation?
Cardiovascular magnetic resonance (CMR) is a transformative imaging technology that
is increasingly being used for the non-invasive evaluation of the expanding cardiomyopathy
population. It represents the gold standard for the assessment of cardiac volumes,
function and mass, due to its high spatial, temporal and contrast resolution, and
true three-dimensional coverage of the heart [
[1]
,
[2]
].- Porcari A.
- De Luca A.
- Grigoratos C.
- Biondi F.
- Faganello G.
- Vitrella G.
- et al.
Arrhythmic risk stratification by cardiac magnetic resonance tissue characterization:
disclosing the arrhythmic substrate within the heart muscle.
Heart Fail Rev. 2020 Jun 20; (Online ahead of print)https://doi.org/10.1007/s10741-020-09986-0
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Heart, Lung and CirculationAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Role of cardiac magnetic resonance imaging in patients with idiopathic ventricular arrhythmias.Curr Cardiol Rev. 2019; 15: 12-23
- Arrhythmic risk stratification by cardiac magnetic resonance tissue characterization: disclosing the arrhythmic substrate within the heart muscle.Heart Fail Rev. 2020 Jun 20; (Online ahead of print)https://doi.org/10.1007/s10741-020-09986-0
- Impact of late gadolinium enhancement on mortality, sudden death and major adverse cardiovascular events in ischemic and nonischemic cardiomyopathy: a systematic review and meta-analysis.Int J Cardiol. 2018; 254: 230-237
- Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults.Circ Arrhythm Electrophysiol. 2011; 4: 303-309
- Cardiovascular magnetic resonance-GUIDEd management of mild to moderate left ventricular systolic dysfunction (CMR GUIDE): study protocol for a randomized controlled trial.Ann Noninvasive Electrocardiol. 2017; 22
- Septal late gadolinium enhancement and arrhythmic risk in genetic and acquired non-ischaemic cardiomyopathies.Heart Lung Circ. 2020; 29: 1356-1365
- Identifying nonischemic cardiomyopathy patients who would benefit from an implantable cardioverter-defibrillator: can late gadolinium enhancement on cardiovascular magnetic resonance imaging help?.Am Heart J. 2020; 221: 177-179
- Prevalence and prognostic value of concealed structural abnormalities in patients with apparently idiopathic ventricular arrhythmias of left versus right ventricular origin: a magnetic resonance imaging study.Circ Arrhythm Electrophysiol. 2014; 7: 456-462
- Risk Stratification of patients with apparently idiopathic premature ventricular contractions: a multicenter international CMR registry.JACC Clin Electrophysiol. 2020; 6: 722-735
- Cardiac fibrosis and arrhythmogenesis.Compr Physiol. 2017; 7: 1009-1049
Article info
Publication history
Published online: July 11, 2020
Identification
Copyright
© 2020 Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ).
